|
Characteristic
|
No. of patients
|
%
|
|---|
|
Patients evaluable
|
70
|
100
|
|
Age, years
| | |
|
Median (range)
|
65 (32–75)
| |
|
Sex
| | |
|
Male
|
41
|
58.5
|
|
Female
|
29
|
41.5
|
|
Response to prior chemotherapy
| | |
|
Yes
|
44
|
63
|
|
No
|
26
|
37
|
|
Status of primary tumor
| | |
|
Resected
|
25
|
36
|
|
Unresected
|
45
|
64
|
|
Tumor histology
| | |
|
Diffuse
|
33
|
47.2
|
|
Intestinal
|
29
|
41.4
|
|
Unknown
|
8
|
11.4
|
|
ECOG PS
| | |
|
0
|
10
|
14.5
|
|
1
|
40
|
57
|
|
2
|
20
|
28.5
|
|
Number of metastatic sites
| | |
|
1
|
17
|
24
|
|
2
|
32
|
46
|
|
3
|
21
|
30
|
|
Site of metastases
| | |
|
Liver
|
48
|
68.5
|
|
Nodes
|
41
|
58.5
|
|
Peritoneum
|
41
|
58.5
|
|
Lung
|
13
|
18.5
|
|
Bone
|
6
|
8.5
|
|
PFS under first-line chemotherapy
| | |
|
≥ 6 months
|
42
|
60
|
|
< 6 months
|
28
|
40
|
|
Chemotherapy-free interval
| | |
|
> 3 months
|
38
|
54
|
|
< 3 months
|
32
|
46
|
- Abbreviations: ECOG PS Eastern Cooperative Oncology Group Performance Status.
